Strategic Note: Platforms must include a visual injection map
About 59.8% of the study sample had overweight/obesity and 41.9% had T2D
This personalized assessment ensures you receive the care that best supports your long-term wellness, even if your BMI doesnt meet traditional criteria
In two studies examining the 6-month effects of semaglutide, patients with metabolic dysfunction-associated steatotic liver diseases (MASLD) and showed reduced skeletal muscle steatosis with preservation of muscle mass [86], whereas in patients with MASLD and human immunodeficiency virus, semaglutide led to a 9.3% decrease in psoas muscle volume with no change in muscle fat fraction [87]
This combination of efficacy, familiarity, and convenience positions oral semaglutide as a compelling option for practices already offering medical weight lossor those considering adding it
Choose a lower concentration so that your target dose falls on a readable syringe marking